Scopolamine
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 1 | SUPPLYING |
| Padagis Israel Pharmaceuticals Ltd | generic | 3 | EXITED 2028 |
Shortages, recalls, and registration changes attached to this drug concept.
Scopolamine Transdermal System — reported in shortage by Padagis US LLC. Therapeutic category: Gastroenterology, Neurology, Other.
Scopolamine Transdermal System — reported in shortage by Padagis US LLC. Therapeutic category: Gastroenterology, Neurology, Other.
Defective delivery system — Recalling firm: L. Perrigo Company — Nationwide in the U.S.A.
